Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial

Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy

(2017) Matthew J. Murray et al.   INTERNATIONAL JOURNAL OF CANCER

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours

(2015) Matthew J Murray et al.   BRITISH JOURNAL OF CANCER

Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study

(2015) Stewart Goldman et al.   JOURNAL OF CLINICAL ONCOLOGY

Consensus on the management of intracranial germ-cell tumours

(2015) Matthew J Murray et al.   LANCET ONCOLOGY

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

(2015) Leticia De Mattos-Arruda et al.   Nature Communications

Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas

(2014) Shintaro Fukushima et al.   ACTA NEUROPATHOLOGICA

Novel somatic and germline mutations in intracranial germ cell tumours

(2014) Linghua Wang et al.   NATURE

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease

(2013) G. Calaminus et al.   NEURO-ONCOLOGY

Primary chemotherapy for intracranial germ cell tumors: Results of the third international CNS germ cell tumor study

(2010) Nasjla Saba da Silva et al.   PEDIATRIC BLOOD & CANCER